108 related articles for article (PubMed ID: 25882983)
1. Nilotinib, imatinib, and GIST therapy.
Garcia del Muro X
Lancet Oncol; 2015 May; 16(5):483-4. PubMed ID: 25882983
[No Abstract] [Full Text] [Related]
2. Nilotinib versus imatinib for GIST.
Gougis P; Paci A; Coriat R; Urien S; Mir O
Lancet Oncol; 2015 Jul; 16(7):e311. PubMed ID: 26149879
[No Abstract] [Full Text] [Related]
3. Nilotinib versus imatinib for GIST - Authors' reply.
Blay JY; Hurh E; Green S; Novick S
Lancet Oncol; 2015 Jul; 16(7):e311-2. PubMed ID: 26149878
[No Abstract] [Full Text] [Related]
4. Gastrointestinal cancer: Management of GIST--go beyond imatinib: treat resistant subtypes.
Pantaleo MA; Biasco G
Nat Rev Clin Oncol; 2015 Aug; 12(8):440-2. PubMed ID: 26077043
[No Abstract] [Full Text] [Related]
5. Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
Blay JY; Shen L; Kang YK; Rutkowski P; Qin S; Nosov D; Wan D; Trent J; Srimuninnimit V; Pápai Z; Le Cesne A; Novick S; Taningco L; Mo S; Green S; Reichardt P; Demetri GD
Lancet Oncol; 2015 May; 16(5):550-60. PubMed ID: 25882987
[TBL] [Abstract][Full Text] [Related]
6. Rechallenge with imatinib in GIST: is more always RIGHT?
Urban D; Lewin J; Collins IM; Mooi J; Jefford M
Lancet Oncol; 2014 Jan; 15(1):e2-3. PubMed ID: 24384490
[No Abstract] [Full Text] [Related]
7. Combination treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor.
Bompas E; Velay B; Blay JY
Leuk Lymphoma; 2004 Nov; 45(11):2353-4. PubMed ID: 15512830
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant imatinib in GIST: a self-fulfilling prophecy, or more?
Hohenberger P
Lancet; 2009 Mar; 373(9669):1058-60. PubMed ID: 19303138
[No Abstract] [Full Text] [Related]
9. Rechallenge of drugs in the era of targeted therapy.
Nishida T; Doi T
Lancet Oncol; 2013 Nov; 14(12):1143-5. PubMed ID: 24140185
[No Abstract] [Full Text] [Related]
10. Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib.
Murray M; Hatcher H; Jessop F; Williams D; Carroll N; Bulusu R; Judson I
Pediatr Blood Cancer; 2008 Feb; 50(2):386-8. PubMed ID: 17729245
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
12. Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor.
Agulnik M; Giel JL
Am J Clin Oncol; 2014 Aug; 37(4):417-22. PubMed ID: 22772433
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of recurrent or metastatic gastrointestinal stromal tumor: surgery or not].
Shi YQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Mar; 15(3):225-7. PubMed ID: 22454163
[TBL] [Abstract][Full Text] [Related]
14. Adherence to imatinib therapy in patients with gastrointestinal stromal tumors.
Blay JY; Rutkowski P
Cancer Treat Rev; 2014 Mar; 40(2):242-7. PubMed ID: 23931926
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal stromal tumours bigger than 20 cm: experience with imatinib chemotherapy in neoadjuvant intention].
Girotti P; Rolinger J; Kopp HG; Königsrainer A; Ladurner R
Z Gastroenterol; 2014 Jan; 52(1):50-4. PubMed ID: 24420799
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J; Dang YZ; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
[TBL] [Abstract][Full Text] [Related]
18. 'Time is a GIFT in GIST'--the medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor.
Sevinc A; Camci C
Chemotherapy; 2009; 55(1):11-4. PubMed ID: 18974643
[TBL] [Abstract][Full Text] [Related]
19. Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors.
Blanke CD
JAMA; 2012 Mar; 307(12):1312-4. PubMed ID: 22453573
[No Abstract] [Full Text] [Related]
20. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
